NuVasive, Inc. (NASDAQ:NUVA) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 2.06%.
NuVasive, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 25.93% to $0.34 in the quarter versus EPS of $0.27 in the year-earlier quarter.
Revenue: Rose 10.39% to $165.8 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: NuVasive, Inc. reported adjusted EPS income of $0.34 per share. By that measure, the company beat the mean analyst estimate of $0.21. It beat the average revenue estimate of $156.35 million.
Quoting Management: Alex Lukianov, Chairman and Chief Executive Officer, said, “We are very proud of our strong close to 2012 and excellent revenue growth of 15% with profit translation. As we embark on 2013, we are excited to build upon our momentum with growing clinical evidence, game-changing new product launches, an energized sales force, and our expansion into new international markets. Over the last decade, NuVasive has positively changed the lives of over 100,000 spine patients through minimally invasive surgery with our XLIF procedure. We are highly focused on continually disrupting the global spine industry through innovation with advanced procedural solutions and executing to a long term plan of evolving into a $1 billion company with steadily increasing profitability. Our proven, three pillar market share taking strategy of Superior Outcomes, Absolute Responsiveness, and Speed of Innovation will sustain our future growth toward the #3 position within the global spine industry.”
Key Stats (on next page)…